The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
18 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,330,166 in first-year total cost, median $133,934.
Most frequent study sections
- Special Emphasis Panel[ZAI1 RD-W (J1)]9
- Special Emphasis Panel[ZAI1 SAS-W (J1)]9
Most frequent institutions
- INSTITUTE/RESEARCH/BIOTECHNOLOGY FDN3
- ASOCIACION BENEFICA PRISMA1
- CHILD HEALTH RESEARCH FOUNDATION1
- CHULALONGKORN UNIVERSITY1
- FEDERAL UNIVERSITY OF BAHIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Understanding the persistence of Dengue epidemic and associated risk factors in Urban Bamako Mali1R01AI191323-01 | KANE, FOUSSEYNI | UNIV OF SCIENCES, TECH & TECH OF BAMAKO | $147,290 | ZAI1 |
| 2025 | Assessing mechanisms for the persistence of RNA viruses in bats using a captive and wild Eidolon helium colonies1R01AI183446-01A1 | QUAYE, OSBOURNE | UNIVERSITY OF GHANA | $146,125 | ZAI1 |
| 2025 | Investigating the effectiveness of oral rabies vaccination in the control of canine and human rabies1R01AI183508-01A1 | LUGELO, AHMED | GLOBAL ANIMAL HEALTH TANZANIA | $139,387 | ZAI1 |
| 2025 | Effect of Mesophilic Anaerobic Biodigestion on Taenia solium Egg Survival, Viability, and Infectivity: An Approach for Future Implementation to Control Helminth Infections.1R01AI183408-01A1 | GONZALES-GUSTAVSON, ELOY ANIBAL | ASOCIACION BENEFICA PRISMA | $134,067 | ZAI1 |
| 2025 | Unravelling of protein trafficking in Trypanosoma cruzi, the agent of Chagas disease.1R01AI191327-01 | MUCCI, JUAN | INSTITUTE/RESEARCH/BIOTECHNOLOGY FDN | $133,800 | ZAI1 |
| 2025 | High-throughput analysis of dynamics of antibody responses against defined epitopes: prioritization of diagnostic and prognostic markers for Chagas disease1R01AI183396-01A1 | AGUERO, FERNAN GONZALO | INSTITUTE/RESEARCH/BIOTECHNOLOGY FDN | $133,746 | ZAI1 |
| 2025 | The role of an unusual variant nucleosome in Toxoplasma gondii life cycle1R01AI183372-01A1 | ANGEL, SERGIO OSCAR | INSTITUTE/RESEARCH/BIOTECHNOLOGY FDN | $133,693 | ZAI1 |
| 2025 | Antigen presentation during Trypanosoma cruzi infection: in search of a new effective vaccine1R01AI183370-01A1 | ALLOATTI, ANDRES | INSTITUTE OF MOLECULAR /CELLULAR BIOLOGY | $123,280 | ZAI1 |
| 2025 | Elucidation of the role of Plasmodium falciparum folate transporters in antifolates transport and implication on drug design1R01AI183391-01A1 | HOARAU, MARIE | NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY | $60,588 | ZAI1 |
| 2024 | Real-World Impact of Next Generation Insecticidal Nets for Malaria Control in Rural Western Kenya1R01AI183393-01 | MANGENI, JUDITH | MOI UNIVERSITY COLLEGE OF HEALTH SCIENCES | $141,470 | ZAI1 |
| 2024 | Identification of predictive biomarkers for severe acute leptospirosis and its long-term sequelae1R01AI183353-01 | SRISAWAT, NATTACHAI | CHULALONGKORN UNIVERSITY | $137,229 | ZAI1 |
| 2024 | IMPILO: Investigating novel 6-Month regimens for RR-TB in Pregnancy and Lactation1R01AI183355-01 | LOVEDAY, MARIAN | MEDICAL RESEARCH COUNCIL OF SOUTH AFRICA | $135,502 | ZAI1 |
| 2024 | Investigating the dynamics of Salmonella Typhi and bacteriophages in the environment and the human gut1R01AI183463-01 | SAHA, SENJUTI | CHILD HEALTH RESEARCH FOUNDATION | $134,955 | ZAI1 |
| 2024 | Treatment of isoniazid-resistant tuberculosis: closing evidence gaps on safety, effectiveness, and pharmacokinetics of the standard regimen1R01AI183405-01 | MENDOZA, ALBERTO | SOCIOS EN SALUD SUCURSAL PERU | $134,340 | ZAI1 |
| 2024 | Wetlands in Argentinaas hubs for exchange and emigration of bird-borne arboviruses1R01AI183506-01 | DIAZ, ADRIAN | NATIONAL COUNCIL SCIENTIFIC & TECH RES | $133,664 | ZAI1 |
| 2024 | The skin microbiome and fungal infections of indigenous Malaysians1R01AI183416-01 | LIM, YVONNE AL | UNIVERSITY OF MALAYA | $124,924 | ZAI1 |
| 2024 | Adipocytes and inflammation in the cutaneous leishmaniasis outcome1R01AI183392-01 | CARVALHO, LUCAS P | FEDERAL UNIVERSITY OF BAHIA | $120,226 | ZAI1 |
| 2024 | An extracellular vesicle component as a candidate to control cryptococcosis.1R01AI183314-01 | NOSANCHUK, JOSHUA DRODRIGUES, MARCIO LOURENCO | FUNDACAO OSWALDO CRUZ | $115,880 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.